InsiderTrades.com logo
Paul L. Berns net worth and biography

    Paul Berns Biography and Net Worth

    Director of Kardigan

    Paul brings over 30 years of pharmaceutical and biotechnology expertise and is currently a managing director of ARCH Venture Partners, which he joined in 2018. He is also co-founder and executive chairman of Neumora Therapeutics, chairman for Happy AI and NICO Therapeutics, and a member of the boards of Mirador Therapeutics, Areteia Therapeutics, Metsera Therapeutics, Epirium, Ollin Biosciences and Unity Biotechnology. Paul previously served as president, CEO and chairman at Anacor Pharmaceuticals (acquired by Pfizer), president and CEO of Allos Therapeutics (acquired by Spectrum Pharmaceuticals) and Bone Care International (acquired by Genzyme), as well as co-founder and chairman of HI-Bio (acquired by Biogen). Paul has also held senior management roles at Abbott Laboratories, BASF Pharmaceuticals/Knoll (acquired by Abbott) and Bristol Myers Squibb. Paul previously served on the boards of EQRX, Jazz Pharmaceuticals, PLC, MC2 Therapeutics, Menlo Therapeutics, XenoPort, Allos Therapeutics and Bone Care International. He holds a B.S. in Economics from the University of Wisconsin.

    What is Paul L. Berns' net worth?

    The estimated net worth of Paul L. Berns is at least $396.06 million as of June 22nd, 2026. Berns owns 15,042,035 shares of Kardigan stock worth more than $396,056,782 as of June 29th. This net worth estimate does not reflect any other investments that Berns may own. Learn More about Paul L. Berns' net worth.

    Has Paul L. Berns been buying or selling shares of Kardigan?

    During the last ninety days, Paul L. Berns has bought $20,000,000.00 in shares of Kardigan stock. Most recently, on Monday, June 22nd, Paul L. Berns bought 1,250,000 shares of Kardigan stock. The stock was acquired at an average cost of $16.00 per share, with a total value of $20,000,000.00. Following the completion of the transaction, the director now directly owns 15,042,035 shares of the company's stock, valued at $240,672,560. Learn More on Paul L. Berns' trading history.

    Are insiders buying or selling shares of Kardigan?

    In the last year, Kardigan insiders bought shares 2 times. They purchased a total of 2,500,000 shares worth more than $40,000,000.00. The most recent insider tranaction occured on June, 22nd when Director Paul L Berns bought 1,250,000 shares worth more than $20,000,000.00. Learn More about insider trades at Kardigan.

    Information on this page was last updated on 6/22/2026.

    Paul L. Berns Insider Trading History at Kardigan

    Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
    6/22/2026Buy1,250,000$16.00$20,000,000.0015,042,035View SEC Filing Icon  
    See Full Table

    Paul L. Berns Buying and Selling Activity at Kardigan

    This chart shows Paul L Berns's buying and selling at Kardigan by year and by quarter.

    Skip ChartChart Data in Insider Trading History Table

    Kardigan Company Overview

    Read More

    Today's Range

    Now: $25.85
    Low: $23.60
    High: $27.00

    50 Day Range

    MA: N/A

    2 Week Range

    Now: $25.85
    Low: $16.25
    High: $27.00

    Volume

    980,506 shs

    Average Volume

    659,414 shs

    Market Capitalization

    $2.31 billion

    P/E Ratio

    N/A

    Dividend Yield

    N/A

    Beta

    N/A